Related Experiment Video
Updated: Jan 8, 2026

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Genomic and functional characterization of a novel temperate Coventryvirus phage infecting Staphylococcus
Patoo Withatanung1, Sukanya Apiratwarrasakul2, Pathomporn Sresuwadjarey2
1Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Abstract:
The rise of methicillin-resistant Staphylococcus pseudintermedius (MRSP), a multidrug-resistant zoonotic pathogen with strong biofilm-forming ability, highlights the urgent need for alternative therapies. Here, we report the isolation and comprehensive characterization of vB_SpsS_VL4 (VL4), a novel temperate phage obtained from sewage using a clinical MRSP isolate. VL4 genome (39,788 bp) contains 68 open reading frames (ORFs) with no virulence, resistance, or toxin genes and encodes lysis proteins with Cysteine, Histidine-dependent Amidohydrolase/Peptidase (CHAP) domains. Genomic and phylogenetic analyses classified VL4 as a new species within the Coventryvirus genus. Despite its temperate nature, VL4 demonstrated efficient replication (latent period 50 min; burst size 56 PFU per cell), remained viable at neutral pH and temperatures up to 37 °C, and significantly suppressed the host bacterial growth. Among 31 S. pseudintermedius clinical isolates, 27 (87%) strains were susceptible to VL4, while no activity was detected against Staphylococcus aureus. Moreover, VL4 inhibited biofilm formation and partially degraded mature MRSP biofilms. Collectively, these findings identify VL4 as a promising Coventryvirus phage with potential for future engineering and therapeutic development against difficult-to-treat MRSP infections.
Insights
A novel bacteriophage, vB_SpsS_VL4 (VL4), effectively targets methicillin-resistant Staphylococcus pseudintermedius (MRSP) infections. This phage suppresses bacterial growth, inhibits biofilm formation, and shows potential for therapeutic development.
Area of Science:
- Microbiology
- Virology
- Bacteriophage Therapy
Background:
- Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is a multidrug-resistant zoonotic pathogen.
- MRSP exhibits significant biofilm-forming capabilities, complicating treatment strategies.
- There is an urgent need for alternative therapeutic approaches against MRSP.
Purpose of the Study:
- To isolate and characterize a novel bacteriophage for targeting MRSP.
- To evaluate the efficacy of the isolated phage against MRSP growth and biofilm formation.
- To assess the phage's potential for therapeutic applications.
Main Methods:
- Isolation of bacteriophage vB_SpsS_VL4 (VL4) from sewage using a clinical MRSP isolate.
- Genomic sequencing and analysis of the VL4 phage.
- Assessment of VL4's lytic activity, replication, and stability under various conditions.
- Testing VL4 susceptibility against a panel of S. pseudintermedius clinical isolates and S. aureus.
- Evaluation of VL4's impact on MRSP biofilm formation and degradation.
Main Results:
- VL4, a temperate phage, possesses a 39,788 bp genome with 68 ORFs, lacking virulence, resistance, or toxin genes.
- VL4 demonstrated efficient replication, stability at 37°C and neutral pH, and suppressed MRSP growth.
- 87% of tested S. pseudintermedius isolates were susceptible to VL4, with no activity against S. aureus.
- VL4 significantly inhibited MRSP biofilm formation and partially degraded existing biofilms.
Conclusions:
- VL4 is a novel temperate phage, classified as a new species within the Coventryvirus genus.
- VL4 exhibits potent antibacterial activity against MRSP, including inhibition of biofilm formation.
- VL4 represents a promising candidate for the development of phage-based therapies against challenging MRSP infections.
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Bacterial Phylum Tenericutes
Bacterial Phylum Spirochaetes

